Mar 01, 2022 / 09:30PM GMT
Operator
Good afternoon, and thank you for joining us today for Neoleukin Therapeutics conference call. (Operator Instructions) As a reminder, today's conference call is being recorded. I would now like to turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics. Julie, Please go ahead.
Julie Rathbun;Rathbun Communications;President -
Thank you. Good afternoon, and welcome to Neoleukin Therapeutics Year-End 2021 Conference Call. Joining me on the call today from Neoleukin are Jonathan Drachman, CEO; Priti Patel, CMO; and Sean Smith, Vice President, Finance. Today's call is being recorded. It will be available for replay on the Investor Relations section of the Neoleukin website approximately 2 hours after the call for at least 30 days.
Before we start, I'd like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgments, intentions, beliefs and expectations about future events, strategies, product candidates and operating
Q4 2021 Neoleukin Therapeutics Inc Earnings Call Transcript
Mar 02, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers